Blue Trust Inc. Raises Stake in DaVita Inc. (NYSE:DVA)

Blue Trust Inc. increased its stake in shares of DaVita Inc. (NYSE:DVA) by 150.9% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 567 shares of the company’s stock after purchasing an additional 341 shares during the period. Blue Trust Inc.’s holdings in DaVita were worth $87,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in DVA. UMB Bank n.a. lifted its holdings in DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Copia Wealth Management purchased a new stake in DaVita during the 4th quarter worth about $30,000. SBI Securities Co. Ltd. purchased a new stake in DaVita during the 4th quarter worth about $41,000. Coppell Advisory Solutions LLC lifted its holdings in DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock worth $45,000 after purchasing an additional 100 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan purchased a new stake in DaVita during the 4th quarter worth about $55,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

NYSE:DVA opened at $140.41 on Thursday. The company has a quick ratio of 1.20, a current ratio of 1.25 and a debt-to-equity ratio of 23.18. The stock has a market cap of $10.60 billion, a P/E ratio of 13.92, a PEG ratio of 0.97 and a beta of 1.11. The business’s 50-day moving average price is $139.42 and its two-hundred day moving average price is $149.73. DaVita Inc. has a twelve month low of $131.76 and a twelve month high of $179.60.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Monday, May 12th. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.75 by $0.25. The firm had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The company’s revenue was up 5.0% on a year-over-year basis. During the same period in the prior year, the company earned $2.26 EPS. As a group, equities analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have weighed in on DVA. Truist Financial lowered their price target on DaVita from $170.00 to $164.00 and set a “hold” rating on the stock in a report on Monday, May 19th. Wall Street Zen raised DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $164.50.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.